ClinicalTrials.Veeva

Menu

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

M

Menoufia University

Status

Completed

Conditions

Prostate Disease
Prostate Obstruction
Prostate Hypertrophy
Prostatic Neoplasms

Treatments

Drug: Single dose tamsulosin 0.4mg
Drug: Double dose tamsulosin 0.4mg

Study type

Interventional

Funder types

Other

Identifiers

NCT05834270
SD vs DD Tamsulosin

Details and patient eligibility

About

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

Enrollment

60 patients

Sex

Male

Ages

50 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age more than 50 years
  • moderate to severe lower urinary tract symptoms

Exclusion criteria

  • prostatic cancer
  • urethral stricture
  • prostate surgery
  • Neurogenic bladder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Single dose tamsulosin 0.4mg
Active Comparator group
Description:
Single dose tamsulosin 0.4mg
Treatment:
Drug: Single dose tamsulosin 0.4mg
Double dose tamsulosin 0.4mg
Active Comparator group
Description:
Double dose tamsulosin 0.4mg
Treatment:
Drug: Double dose tamsulosin 0.4mg

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems